MBA Capital, one of our French Partners, has assisted LABORATOIRE MIDAC in its sale to the CENTRE TESTING INTERNATIONAL (CTI) group, a pioneer and leader in testing and certification services in China, listed in Shenzhen. This transaction reinforces CTI's international expansion strategy and opens a new stage of development for LABORATOIRE MIDAC.
A Lille laboratory with recognised know-how was sold to a world leader
Founded in 1984 in Lille and chaired since 2010 by Raphaël Dugué, LABORATOIRE MIDAC is an independent player in microbiology. For more than forty years, it has been providing research, testing and control services for the chemical, cosmetic and pharmaceutical industries.
His specialisation covers the evaluation of the effectiveness of disinfectants and preservatives, the microbiological quality control of products, as well as the dosage of antibiotics. Its scientific reliability and accreditations make it a trusted partner for its customers in France and Europe.
A strategic acquisition for CTI and prospects for MIDAC
Founded in 2003 and headquartered in Shenzhen, CENTRE TESTING INTERNATIONAL GROUP CO., LTD. (CTI) is China's first publicly traded company in the testing and certification industry. The group has established itself as a leading player in ICT (Testing, Inspection, Certification) services, offering complete solutions in testing, inspections, certifications, metrology, audits and technical services. CTI operates a network of approximately 160 laboratories and more than 260 offices in more than 90 cities around the world and works for more than 100,000 customers.
With the integration of MIDAC through the acquisition of 100% of the shares, CTI now benefits from an essential anchor in Europe, at the heart of a leading cosmetics and pharmaceutical ecosystem.
This acquisition makes it possible to:
- Expand CTI's global reach in everyday chemical and microbiological testing
- Strengthen its portfolio of international customers
- to support major European cosmetic brands in their export compliance procedures, particularly to China
- Accelerate the implementation of its external growth strategy in Europe
This operation is part of a movement of international consolidation of testing laboratories. By joining a player of CTI's size, LABORATOIRE MIDAC now benefits from new development prospects and a foothold within a global network, while pursuing its mission to serve its customers and its teams.
MIDAC is a remarkable European institution in the field of microbiological testing. His technical expertise is highly synergistic with CTI's strategic direction. With this acquisition, CTI will fully integrate MIDAC's technical capabilities and local resources, further optimise its global service network, and provide its customers with more efficient, accurate and internationally compliant testing services. "says Shentu Xianzhong, CEO of CTI Group.
MBA Capital at the heart of the successful sale
MBA Capital, through Marc Burden, accompanied the director of LABORATOIRE MIDAC, Raphaël Dugué, throughout the sale process.
The mission covered:
- Preparation of the process and presentation of the company to targeted counterparties
- Finding buyers
- taking charge of all exchanges from the first contacts with the buyer, in order to structure and secure the process
- follow-up of audits and exchanges, including the linguistic and cultural interface between the French manager and the Chinese buyer
- cooperation with the French authorities (procedure for the control of foreign investments by Bercy)
An atypical mission, marked by the size and international scope of the buyer, as well as by cultural and regulatory differences, which required a strong involvement of MBA Capital to ensure fluidity, pedagogy and proximity throughout the process.
MBA Capital, and more particularly Marc Burden, have always been by my side from the search for buyers to the closing. In a project as impactful as the sale of a company, it is important to be as supported as possible. Each subject was treated with the same involvement as if Marc Burden were selling his own company. MBA Capital's international dimension has made it possible to find high-level buyers who will offer Laboratoire MIDAC great development prospects. A big thank you to the MBA Capital team. "
For Raphaël Dugué, director of LABORATOIRE MIDAC, "this operation was a particularly enriching experience for us: multicultural, demanding and conducted in front of interlocutors of a very high level. This pushed us to further raise our standards of support, in a context where we had to manage financial, technical and human issues at the same time. I remember above all the quality of the exchanges and the professionalism of all the parties."